Author

Marie Alma

Centre National de la Recherche Scientifique

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

Anne S. DejeaniD· 1 shared Anne-Laure IscacheiD· 1 shared Anne-Louise Le DorzeiD· 1 shared Baptiste Texier· 1 shared Bernard KlonjkowskiiD· 1 shared Daniel Alvarez‐FischeriD· 1 shared David FrieseriD· 1 shared Lisaydi Dominguez-Coronado· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Anne S. DejeanORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Microglial Foxo3 shapes dopaminergic vulnerability in Parkinson disease

Baptiste Texier, Sarah Roudaud, Quentin Husson, Morgane Prime, Marie Alma, Lisaydi Dominguez-Coronado, David Frieser, Anne-Louise Le Dorze, Margot Zahm, Anne-Laure Iscache, Daniel Alvarez‐Fischer, Anne S. Dejean, Bernard Klonjkowski, Stéphane Hunot, Séverine Fruchon, Marion Szelechowski

This study identifies Foxo3 as a key regulator of dopaminergic vulnerability through microglial mechanisms, showing that baseline microglial state, rather than acute transcriptional responses, determines neurodegeneration in Parkinson's disease.

bioRxiv · May 23, 2026 · PreprintNeuroscience